2,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96%, 1g

Iodine, min. 99.5%, Ph.Eur., resublimated, 100 g, glass packaging

D-(+)-Maltose monohydrate, 95.0%, 500g

(2R,3R,4R,5S)-6-(Octylamino)hexane-1,2,3,4,5-pentanol, 95.0%, 25g

trans N,N'- Dimethylcyclohexane-1,2-diamine, 99.0%, 10g

9-(2-Chloro-6-fluorobenzyl)-9H-purin-6-amine, 95.0%, 250mg

2-Bromo-4-phenylthiazole, 97.0%, 5g

2H-1,4-Benzodiazepin-2-one, 3-amino-1,3-dihydro-5-phenyl-, (3S)-, 98%, 1g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine, 98%, 10g

N,N-DIMETHYL-CYCLOHEXANE-1,3-DIAMINE, 1g

2,5-Dimethyl 3-hydroxythiophene-2,5-dicarboxylate, 97%, 1g

Methyl 3-Amino-2-methylbenzoate>98.0%(GC)(T)5g

3-((2-CHLOROPHENYL)THIO)-6-(4-MORPHOLINOPHENYL)-6-(THIOPHEN-3-YL)PIPERIDINE-2,4-DIONE, 95%, 10mg